Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex

被引:41
作者
Yamada M. [1 ]
Takahashi K. [1 ]
Tsunoda M. [1 ]
Nishioka G. [2 ]
Kudo K. [2 ]
Ohata H. [1 ]
Kamijima K. [2 ]
Higuchi T. [3 ]
Momose K. [1 ]
Yamada M. [1 ]
机构
[1] Department of Pharmacology, Showa University, School of Pharmaceutical Sciences, Tokyo
[2] Department of Psychiatry, Showa University School of Medicine, Tokyo
[3] Kohnodai Hospital, National Ctr. of Neurol./Psychiatry, Chiba
[4] Department of Psychiatry, Showa Univ. Karasuyama Hospital, Setagaya, Tokyo 157-8577
基金
日本学术振兴会;
关键词
Depression; Differential cloning; Gene expression; Microarray; SSRI;
D O I
10.1038/sj.tpj.6500135
中图分类号
学科分类号
摘要
The biological basis for the therapeutic mechanisms of depression is still unknown. We have previously performed expressed-sequence tag (EST) analysis to identify some molecular machinery responsible for antidepressant effect. Then, we developed our original cDNA microarray, on which cDNA fragments identified as antidepressant-related genes/ESTs were spotted. In this study, with this microarray followed by Western blot analysis, we have demonstrated the induction of vesicle-associated membrane protein 2 (VAMP2/synaptobrevin-2) in rat frontal cortex not only after chronic antidepressant treatment, but also after repated electroconvulsive treatment. On the other hand, expression of SNAP-25 and syntaxin-1 was not changed by these treatments. These components make a soluble N- ethylmaleimide-sensitive fusion protein attachment protein receptor complex with VAMP2 and mediate the synaptic vesicle docking/fusion machiner. In conclusion, it is suggested that VAM2/synaptobrevin-2 plays important roles in the antidepressant effects. Our results may contribute to a novel model for the therapeutic mechamism of depression and new molecular targets for the development therapeutic agents.
引用
收藏
页码:377 / 382
页数:5
相关论文
共 25 条
[1]  
Wittchen H.U., Knauper B., Kessler R.C., Lifetime risk of depression, Br. J. Psychiatry, 26 s, pp. 16-22, (1994)
[2]  
Dahmen N., Fehr C., Reuss S., Hiemke C., Stimulation of immediate early gene expression by desipramine in rat brain, Biol. Psychiatry, 42, pp. 317-323, (1997)
[3]  
Torres G., Horowitz J.M., Laflamme N., Rivest S., Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain, Neuroscience, 87, pp. 463-477, (1998)
[4]  
Johansson I.M., Bjartmar L., Marcusson J., Ross S.B., Seckl J.R., Olsson T., Chronic amitriptyline treatment induces hippocampal NGFI-A glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats, Brain Res. Mol. Brain Res., 62, pp. 92-95, (1998)
[5]  
Bjartmar L., Johansson I.M., Marcusson J., Ross S.B., Seckl J.R., Olsson T., Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of anti-depressants in the rat, Psychopharmacology, 151, pp. 7-12, (2000)
[6]  
Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Et al., cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment, J. Neurosci., 20, pp. 4030-4036, (2000)
[7]  
Chen J., Nye H.E., Kelz M.B., Hiroi N., Nakabeppu Y., Hope B.T., Et al., Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments, Mol. Pharmacol., 48, pp. 880-889, (1995)
[8]  
Reti I.M., Baraban J.M., Sustained increase in Narp protein expression following repeated electroconvulsive seizure, Neuropsychopharmacology, 23, pp. 439-443, (2000)
[9]  
Yamada M., Kiuchi Y., Nara K., Kanda Y., Morinobu S., Momose K., Et al., Identification of a novel splice variant of heat shock cognate protein 70 after chronic antidepressant treatment in rat frontal cortex, Biochem. Biophys. Res. Commun., 261, pp. 541-545, (1999)
[10]  
Yamada M., Yamada M., Yamazaki S., Takahashi K., Nishioka G., Kudo K., Et al., Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain, Biochem. Biophys. Res. Commun., 278, pp. 150-157, (2000)